Skip to main content
SpringerLink
Log in

Epidemiology of Dermatomyositis

  • Chapter
Dermatomyositis

The idiopathic inflammatory myopathies are relatively rare diseases that occur throughout the world. The occurrence of DM/PM is uncommon. The absence of reliable epidemiologic data for DM is rather surprising and may relate to several reasons: (i) the rarity of disease, (ii) the lack of consistent use of diagnostic criteria, (iii) the indolent clinical course, (iv) the fact that the numbers result from studies on hospitalized patients, (v) the management of outpatients by physicians from many different specialties (including pediatric and adult rheumatologists, neurologists, dermatologists, other specialists, and general practitioners), and (vi) the lack of prospective studies of associated myositis in connective tissue disease [1].

Dermatomyositis affects both children and adults. The incidence of DM is approximately 10–20 times lower than the incidence of lupus erythematosus, or other connective tissue diseases — systemic sclerosis or rheumatoid polyarthritis [2, 3]. The relative prevalence of DM in relation to PM varies between different studies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Urbano-Marquez A, Casademont J, Grau JM. Polymyositis]dermatomyositis: the current position. Ann Rheum Dis 1991; 50: 191–195.

    Article  PubMed  CAS  Google Scholar 

  2. Dalakas M. Polymyositis, dermatomyositis and inclusion body myositis. N Engl J Med 1991; 325(21): 1487–1498.

    Article  PubMed  CAS  Google Scholar 

  3. Koh ET, Seow A, Ong B, et al. Adult-onset PM/DM: clinical and laboratory features and treatment response in 75 patients. Ann Rheum Dis 1993; 52: 857–861.

    Article  PubMed  CAS  Google Scholar 

  4. Drake L, Dinehart SM, Farmer ER, et al. Guidelines of care for dermatomyositis. J Am Acad Dermatol 1996; 34: 824–829.

    Article  PubMed  CAS  Google Scholar 

  5. Dawkins MA, Jorizzo JL, Walker FO, et al. Dermatomyositis: a dermatology-based case series. J Am Acad Dermatol 1998; 38: 397–404.

    Article  PubMed  CAS  Google Scholar 

  6. Oddis C V, Conte CG, Steen VD, et al. Incidence of PM/DM: a 20-year study of hospital-diagnosed cases in Allegheny County PA, 1963–82. J Rheumatol 1990; 17: 1329–1334.

    PubMed  CAS  Google Scholar 

  7. Medsger TA, Dawson WN, Masi AT. The epidemiology of polymyositis. Am J Med 1970; 48: 715–723.

    Article  PubMed  Google Scholar 

  8. Kurland LT, hauser WA, Ferguson RH, et al. Epidemiologic features of diffuse connective tissue disorders in Rochester, Minn., 1951 through 1967, with special reference to systemic lupus erythematosus. Mayo Clin Proc 1969; 44: 649–663.

    PubMed  CAS  Google Scholar 

  9. Medsger TA, Jr. Polymyositis and dermatomyositis. In: Epidemiology of the Rheumatic Diseases, Lawrence RC, Shulman LE (eds), Gower, New York, 1984; 176–180.

    Google Scholar 

  10. Benbassat J, Gefel D, Larholt K, et al. Prognostic factors in polymyostis/dermatomyositis. A computer-assisted analysis of ninety-two cases. Arthritis Rheum 1985; 28: 249–255.

    Article  PubMed  CAS  Google Scholar 

  11. Kovacs SO, Kovacs SC. Dermatomyositis. J Am Acad Dermatol 1998; 39: 899–920.

    Article  PubMed  CAS  Google Scholar 

  12. Weitoft T. Occurrence of polymyositis in the county of Gävleborg, Sweden. Scand J Rheumatol 1997; 26(2): 104–106.

    PubMed  CAS  Google Scholar 

  13. Patrick M, Buchbinder R, Jolly D, et al. Incidence of inflammatory myopathies in Victoria, Australia, and evidence of spatial clustering. J Rheumatol 1999; 26: 1094–1100.

    PubMed  CAS  Google Scholar 

  14. Fathi M, Dastmalchi M, Rasmussen E, et al. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 2004; 63: 297–301.

    Article  PubMed  CAS  Google Scholar 

  15. Benbassat J, Geffel D, Zlotnick A. Epidemiology of polymyositis-dermatomyositis in Israel, 1960–76. Isr J Med Sci 1980; 16(3): 197–200.

    PubMed  CAS  Google Scholar 

  16. Ahlstrom G, Gunnarsson LG, Leissner P, et al. Epidemiology of neuromuscular diseases, including the postpolio squelae, in a Swedish county. Neuroepidemiology 1993; 12: 262–269.

    Article  PubMed  CAS  Google Scholar 

  17. Dourmishev LA. Dermatomyositis: current aspects. Ph.D. thesis, Sofia, 2002; 140.

    Google Scholar 

  18. Ramanan AV, Feldman BM. Clinical outcomes in juvenile dermatomyositis. Curr Opin Rheumatol 2002; 14: 658–662.

    Article  PubMed  CAS  Google Scholar 

  19. Hanissian AS, Masi AT, Pitrier SE, et al. Polymyositis and dermatomyositis in children: an epidemiologic and clinical comparative analysis. J Rheumatol 1982; 9: 390–394.

    PubMed  CAS  Google Scholar 

  20. Paller AS. Juvenile dermatomyositis and overlap syndromes. Adv Dermatol 1995; 10: 309–326.

    PubMed  CAS  Google Scholar 

  21. Wargula JC. Update on juvenile dermatomyositis: new advances in understanding its etiopathogenesis. Curr Opin Rheumatol 2003; 15(5): 595–601.

    Article  PubMed  CAS  Google Scholar 

  22. Melleson PN, Fung MY, Rosenberg AM. The incidence of pediatric rheumatic disease: results from the Canadian Pediatric Rheumatology Association Disease Registry. J Rheumatol 1996; 23: 1981–1987.

    Google Scholar 

  23. Symmons DPM, Sills JA, Davis SM. The incidence of juvenile dermatomyositis: results from a nation-wide study. Br J Rheumatol 1995; 34: 732–736.

    Article  PubMed  CAS  Google Scholar 

  24. Mendez E P, Lipton R, Ramsey-Goldman R, et al. NIAMS Juvenile DM Registry Physician Referral Group. US incidence of juvenile dermatomyositis, 1995–1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 2003; 49(3): 300–305.

    Article  PubMed  Google Scholar 

  25. Gardner-Medwin JM, Dolezalova P, Cummins C, et al. Incidence of Henoch-Schönlein pur-pura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 2002; 360: 1197–1202.

    Article  PubMed  Google Scholar 

  26. Pachman LM, Hayford JR, Chung A, et al. Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. J Rheumatol 1998; 25(6): 1198–1204.

    PubMed  CAS  Google Scholar 

  27. Peloro TM, Miller OF, Hahn TF, et al. Juvenile dermatomyositis: a retrospective review of a 30-year experience. J Am Acad Dermatol 2001; 45: 28–34.

    Article  PubMed  CAS  Google Scholar 

  28. Malleson P. Juvenile dermatomyositis: a review. J Royal Soc Med 1982; 75: 33–37.

    CAS  Google Scholar 

  29. Chowdhary V, Wakhlu A, Agarwal A, et al. Outcome in juvenile dermatomyositis. Indian Pediatr 2002; 39: 931–935.

    PubMed  Google Scholar 

  30. Pachman LM, Mendez E, Lou H, et al. Parent report of antecedent illness and environmental factors before onset of juvenile dermatomyositis (JDM): NIAMS JDM registry data [abstract]. Arthritis Rheum 1999; 42: S136.

    Google Scholar 

  31. Degos R, Civatte J, Belaich S, et al. The prognosis of adult dermatomyositis. Trans St John's Hosp Dermatol Soc 1971; 37: 98–104.

    Google Scholar 

  32. Marie I, Hatron P Y, Levesque H, et al. The influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine 1998; 78: 139–147

    Article  Google Scholar 

  33. Pachman LM. Juvenile dermatomyositis: immunogenetics, pathophysiology, and disease expression. Rheum Dis Clin North Am 2002; 28: 579–602.

    Article  PubMed  Google Scholar 

  34. Findlay GH, Whiting DA, Sinson I W. Dermatomyositis in the Transvaal and its occurrence in the Bantu. S Afr Med J 1969; 43: 694–697.

    PubMed  CAS  Google Scholar 

  35. Hochberg MC. Epidemiology of polymyositis/dermatomyositis. Mt Sinai J Med 1988; 55: 447–452.

    PubMed  CAS  Google Scholar 

  36. Sontheimer RD. Dermatomyositis: an overview of recent progress with emphasasis on derma-tologic aspects. Dermatol Clin 2002; 20: 387–408.

    Article  PubMed  Google Scholar 

  37. Reed AM. Myositis in children. Curr Opin Rheumatol 2001; 13: 428–433.

    Article  PubMed  CAS  Google Scholar 

  38. Shamin EA, Rider LG, Pandey JP, et al. Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians. Arthritis Rheum 2002; 46: 1885–1893.

    Article  Google Scholar 

  39. Dorph C, Lundberg IE. Idiopathic inflammatory myopathies — myositis. Best Pract Res Clin Rheumatol 2002; 16(5): 817–832.

    Article  PubMed  Google Scholar 

  40. Ginn LR, Lin JP, Plotz PH, et al. Familial autoimmunity in pedigrees of idiopathic inflammatory myopathy patients suggests common genetic risk factors for many autoimmune diseases. Arthritis Rheum 1998; 41: 400–405.

    Article  PubMed  CAS  Google Scholar 

  41. Rider LG, Gurley RC, Pandey JP, et al. Clinical serologic and immunogenetic features of familial idiopathic inflammatory myopathy. Arthritis Rheum 1998; 41: 710–719.

    Article  PubMed  CAS  Google Scholar 

  42. Plamondon S, Dent PB, Reed AM. Familial dermatomyositis. J Rheumatol 1999; 26: 2691–2692.

    PubMed  CAS  Google Scholar 

  43. Davies MG, Hickling P. Familial adult dermatomyositis. Br J Dermatol 2001; 144: 415–416.

    Article  PubMed  CAS  Google Scholar 

  44. Wedgwood RJ, Cook CD, Cohen J. Dermatomyositis: report of 26 cases in children with a discussion of endocrine therapy in 13. Pediatrics 1953; 12: 447–466.

    PubMed  CAS  Google Scholar 

  45. Harati Y, Niakan E, Bergman EW. Childhood dermatomyositis in monozygotic twins. Neurology 1986; 36: 721–723.

    PubMed  CAS  Google Scholar 

  46. Hengstman GJD, van Venrooij WJ, Venkovsky J, et al. The relative prevalence of dermatomyositis and polymyositis in Europe exihibits a latitudinal gradient. Ann Rheum Dis 2000; 59: 141–142.

    Article  PubMed  CAS  Google Scholar 

  47. Christianson HB, Brunsting LA, Perry HO. Dermatomyositis: unusual features, complications, and treatment. Arch Dermatol 1956; 74: 581–584.

    Google Scholar 

  48. Plamondon S, Dent PB, Reed AM. Familial dermatomyositis. J Rheumatol 1999; 26(12): 2691–2692.

    PubMed  CAS  Google Scholar 

  49. Lambie JA, Duff LF. Familial occurrence of dermatomyositis. Case report and a family survey. Ann Intern Med 1963; 59: 839–847.

    PubMed  CAS  Google Scholar 

  50. Henekam RC, Hemstra I, Jennekens FG et al. Juvenile dermatomyositis in first cosins (letter). N Engl J Med 1990; 323: 199.

    Google Scholar 

  51. Andews A, Hickling P, Hutton C. Familial dermatomyositis. Br J Rheumatol 1998; 37: 231–232.

    Article  Google Scholar 

  52. Lewkonia RM, Buxton PH. Myositis in father and daughter. J Neurol Neurosurg Psychiatry 1973; 36: 820–825.

    Article  PubMed  CAS  Google Scholar 

  53. Cassidy JT, Petty R. Dermatomyositis. In: Textbook of Pediatric Rheumatology, Cassidy JT, Petty R (eds), Churchill Livingstone, Edinburgh, 1990; 331–375.

    Google Scholar 

  54. Shamim EA, Rider LG, Miller FW. Update on the genetics of the idiopathic inflammatory myopathies. Curr Opin Rheumatol 2000; 12: 482–491.

    Article  PubMed  CAS  Google Scholar 

  55. Koffman BM, Sivakumar K, Simonis T, et al. HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies. J Neuroimmunol 1998; 84: 139–142.

    Article  PubMed  CAS  Google Scholar 

  56. Reed AM, Ytterberg SR. Genetic and environmental risk factors for idiopathic inflammatory myopathies. Rheum Dis Clin N Am 2002; 28: 891–916.

    Article  Google Scholar 

  57. Werth VP, Callen JP, Ang G, Sullivan KE. Associations of tumor necrosis factor ⃞ and HLA polymorphisms with adult dermatomyositis: implications for a unique pathogenesis. J Invest Dermatol 2002; 119: 617–620.

    Article  PubMed  CAS  Google Scholar 

  58. Reed AM, Pachman L, Ober C. Molecular genetic studies of major histocompatibility complex genes in children with juvenile dermatomyositis: increased risk associated with the HLA-DQA1*0501. Hum Immunol 1991; 32: 235–240.

    Article  PubMed  CAS  Google Scholar 

  59. Friedeman JM, Pachman LM, Maryjowski ML, et al. Immunogenetic studies of juvenile der-matomyositis: HLA-DR antigen frequencies. Arthritis Rheum 1983; 26: 214–216.

    Article  Google Scholar 

  60. Love LA, Leff RL, Fraser DD, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 1991; 70: 360–374.

    Article  PubMed  CAS  Google Scholar 

  61. Arnett FC, Targoff IN, Mimori T, et al. Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four groups with various forms of myositis. Arthritis Rheum 1996; 39: 1507–1518.

    Article  PubMed  CAS  Google Scholar 

  62. Hausmanowa-Petrusewicz I, Kowalska-Oledzka E, Miller F W, et al. Clinical, serological and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum 1997; 40: 1257–1266.

    PubMed  CAS  Google Scholar 

  63. Rider LG, Shamim E, Okada S et al. Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American whites: a tale of two loci. Arthritis Rheum 1999; 42: 1285–1290.

    Article  PubMed  CAS  Google Scholar 

  64. West JE, Reed AM. Analysis of HLA-DM polymorphism in juvenile dermatomyositis(JDM) patients. Hum Immunol 1999; 60: 255–258.

    Article  PubMed  CAS  Google Scholar 

  65. Garlepp MJ. Immunogenetics of inflammatory myopathies. Baillieres Clin Neurol 1992; 2: 579–597.

    Google Scholar 

  66. Furuya T, Hakoda M, Higami K et al. Association of HLA class I and class II Alleles with Myositis Japanese Patients. J Rheumatol 1998; 25: 1109–1114.

    PubMed  CAS  Google Scholar 

  67. Horiki T, Ichikawa Y, Hoshina Y, et al. HLA class II haplotypes associated with pulmonary interstitial lesions of polymyositis/dermatomyositis in Japanese patients. Tissue Antigens 2002; 59: 25–30.

    Article  PubMed  CAS  Google Scholar 

  68. Reed AM, Stirling JD. Association of the HLA-DQA*0501 allele in multiple racial groups with juvenile dermatomyositis. Hum Immunol 1995; 44: 131–135.

    Article  PubMed  CAS  Google Scholar 

  69. Reed AM, Pachman LM, Hayford J, et al. Immunogenetic studies in families of children with juvenile dermatomyositis. J Rheumatol 1998; 25: 1000–1002.

    PubMed  CAS  Google Scholar 

  70. Robb SA, Fielder AH, Saunders CE, et al. C4 complement allotypes in juvenile dermatomy-ositis. Hum Immunol 1988; 22: 31–38.

    Article  PubMed  CAS  Google Scholar 

  71. Moulds JM, Rolih C, Goldstein R, et al. C4 null genes in American whites and blacks with myositis. J Rheumatol 1990; 17: 331–334.

    PubMed  CAS  Google Scholar 

  72. Mimori T. Autoantibodies in connective tissue diseases: clinical significance and analysis of target autoantigens. Intern Med 1999; 38: 523–532.

    Article  PubMed  CAS  Google Scholar 

  73. Goldstein R, Duvic M, Targoff I, et al. HLA-D region genes associated with autoantibody responses to Jo-1 (histidil-tRNA synthetase) and other translation- related factors in myositis. Arthritis Rheum 1990; 33: 657–665.

    Article  Google Scholar 

  74. Targoff IN, Johnson AE, Miller F W. Antibody to signal recognition particle in polymyositis. Arthritis Rheum 1990; 33: 1361–1370.

    Article  PubMed  CAS  Google Scholar 

  75. Gurely RC, Love LA, Targoff IN, et al. Associations among myositis-specific autoantibodies (MSA) and HLA-DQA1 aleles [abstract]. Arthritis Rheum 1991; 34: S137.

    Google Scholar 

  76. Miller OF, Newman ED. Dermatomyositis and polymyositis. In: Cutaneous Medicine and Surgery, Arndt KA, Leboit PC, Robinson JK, et al. (eds), W.B. Saunders, Philadelphia, 1996; 283–290.

    Google Scholar 

  77. Wilson CL, Bradlow A, Wonjarowska F. Cutaneous problems with drug therapy in rheumatoid arthritis. Int J Dermatol 1991; 30: 148–149.

    Article  PubMed  CAS  Google Scholar 

  78. Rider LG, Artlett CM, Foster CB, et al. Polymorphisms in the IL-receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies. Clin Exp Immunol 2000; 121: 47–51.

    Article  PubMed  CAS  Google Scholar 

  79. Greenberg SA, Sanoudou D, Haslett JN, et al. Molecular profiles of inflammatory myopa-thies. Neurology 2002; 59: 1170–1182.

    PubMed  CAS  Google Scholar 

  80. Pachman LM, Tezak Z, Bakay M, et al. Differential gene expression prof iles in DQA1*0501(+) untreated JDM muscle are associated with increased IFN response compared with DQA1*0501 negative JDM. Arthritis Rheum 2001; 44: S399.

    Google Scholar 

  81. Tezak Z, Hoffman E P, Lutz JL, et al. Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis. J Immunol 168: 4154– 4163.

    PubMed  CAS  Google Scholar 

  82. Hoffman EP, Rao D, Pachman LM. Clarifying the boundaries between the inflammatory and dystrophic myopathies: insights from molecular diagnostics and microarrays. Rheum Dis Clin N Am 2002; 28: 743–757.

    Article  Google Scholar 

  83. Werth V P, Bashir M, Zhang W. Photosensitivity in rheumatic diseases. J Invest Dermatol Symp Proc 2004; 9: 57–63.

    Article  CAS  Google Scholar 

  84. Plotz PH. Current comcepts in the idiopathic inflammatory myopathies: polymyositis, der-matomyositis, and related disorders. Ann Intern Med 1989; 111: 143–157.

    PubMed  CAS  Google Scholar 

  85. Targoff IN. Dermatomyositis and polymyositis. Curr Probl Dermatol 1991; 3: 5.

    Article  Google Scholar 

  86. Leff RL, Burgess SH, Miller F W, et al. Distinct seasonal patterns in the onset of adult idi-opathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies. Arthritis Rheum 1991; 34: 1391–1396.

    PubMed  CAS  Google Scholar 

  87. Satoh T, Okano T, Matsui T, et al. Novel autoantibodies against 7SL RNA in patients with polymyositis/dermatomyositis. J Rheumatol 2005; 32: 1727–1733.

    PubMed  CAS  Google Scholar 

  88. Sarkar K, Weinberg CR, Oddis C V, et al. Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups. Arthritis Rheum 2005; 52: 2433–2438.

    Article  PubMed  Google Scholar 

  89. Vegosen LJ, Weinberg CR, O'Hanlon T P, et al. Seasonal birth patterns in myositis subgroups suggest an etiologic role of early environmental exposures. Arthritis Rheum 2007; 56(8): 2719–2728.

    Article  PubMed  Google Scholar 

  90. Brower R, Hengstman GJD, Egberts W V, et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 2001; 60: 116–123.

    Article  Google Scholar 

  91. Okada S, Weatherhead E, Targoff IN, et al. Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease. Arthritis Rheum 2003; 48: 2285–2293.

    Article  PubMed  Google Scholar 

  92. Rennebohm R. Juvenile dermatomyositis. Pediatr Ann 2002; 31: 426–433.

    PubMed  Google Scholar 

  93. Bitnum S, Daeschner C W, Travis LB, et al. Dermatomyositis. J Pediatr 1964; 64: 101–130.

    Article  PubMed  CAS  Google Scholar 

  94. Dourmishev LA, Dourmishev AL, Schwartz RA. Dermatomyositis: cutaneous manifestations of its variants. Int J Dermatol 2002; 41: 625–630.

    Article  PubMed  Google Scholar 

  95. Caproni M, Cardinali C, Parodi A, et al. Amyopathic dermatomyositis, a review by the Italian Group of Immunodermatology. Arch Dermatol 2002; 138: 23–27.

    Article  PubMed  Google Scholar 

  96. Chen YJ, Wu C Y, Shen JL. Predicting factors of malignancy in dermatomyositis and polymy-ositis: a case control study. Br J Dermatol 2001; 144: 825–831.

    Article  PubMed  CAS  Google Scholar 

  97. Ang P, Sugeng M W, Chau SH. Classic and amyopathic dermatomyositis seen at the National Skin Centere of Singapore: a 3-year retrospective review of their clinical characteristics and association with malignancy. Ann Acad Med Singapore 2000; 20: 219–223.

    Google Scholar 

  98. el-Azhary RA, Pakzad S Y. Amyopathic dermatomyositis: retrospective review of 37 cases. J Am Acad Dermatol 2002; 46: 560–565.

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

(2009). Epidemiology of Dermatomyositis. In: Dermatomyositis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79313-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-79313-7_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-79312-0

  • Online ISBN: 978-3-540-79313-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation